Skip to main content
. 2015 Feb 17;75(4):791–803. doi: 10.1007/s00280-015-2701-3

Fig. 1.

Fig. 1

Structure of the binding model for bevacizumab–VEGF165 interaction. The approximation CLRC = CL was used for purposes of model fitting